Protagenic Therapeutics, Inc. (PTIX)
0.59
+0.05
(+9.26%)
USD |
OTCM |
Jan 16, 16:00
Protagenic Therapeutics Shareholders Equity (Quarterly): -4.701M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.21B |
| Vanda Pharmaceuticals, Inc. | 466.00M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
| Theriva Biologics, Inc. | 6.738M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.003M |
| Total Liabilities (Quarterly) | 9.703M |
| Debt to Equity Ratio | -0.8504 |
| Current Ratio | 0.2946 |
| Net Debt Paydown Yield | -39.57% |